Abstract Chondroitin sulfate (CS) and dennatan sulfate (DS) glycosaminoglycans display variability of sulfation in their constituent disaccharide repeats during chain elongation. Since a large proportion of the extracellular matrix of the central nervous system (CNS) is composed ofproteoglycans, CS/DS disaccharide degree and profile of sulfation play important roles in the functional diversity of neurons, brain development, and some of its pathological states. To investigate the sulfation pattern ofCS/DS structures expressed in CNS, we introduced here a novel method based on an advanced system encompassing fully automated chip nanoelectrospray ionization (nanoESI) in the negative ion mode and high capacity ion trap multistage mass spectrometry (MS2_MS3) by collision-induced dissociation (CID). This method, introduced here for the first time in glycomics of brain glycosaminoglycans, was particularly applied to structural investigation of disaccharides obtained by 13- 
Introduction
Extracellular matrix of central nervous system (CNS) serves as supporting structure for cells and rich source of signaling molecules that can influence cell proliferation, survival, migration, and differentiation. A large proportion of this matrix consists ofproteoglycans (PGs)-proteins with long chains of covalently attached polysaccharidescalled glycosaminoglycans (GAGs) [1] .
Chondroitin sulfate (CS) and dermatan sulfate (DS) glycosaminoglycans are covalently linked to a wide range of PG core proteins, with a widespread distribution in mammalian tissue. CS chain backbone encompasses repetitive disaccharide units containing o-glucuronic acid (GleA) and N-acetylgalactosamine (GaINAc) residues. DS is the stereo isomeric variant of CS with varying proportions of Liduronic acid (IdoA). CS/DS-PGs are involved in many biological processes [2] , such as cell proliferation and recognition [3] , cell adhesion and migration, neurite outgrowth [4] , and wound repair [5] . In mammalian tissues, these chains are often found as hybrid CS/DS structures. Their further structural variability during elongation is produced by divergent sulfation in the repeating disaccharide units [6] .
CS, heparan sulfate (HS), and hyaluronic acid are GAGs ubiquitously expressed in neural tissue; however,' the occurrence of keratan sulfate (KS) and DS was also reported [7] . Recent studies have shown that proportions of CS/DS disaccharides in brain change with development! affliction, which suggests that CS/DS species differing in the degree and profile of sulfation are correlated with the functional diversity of neurons [8] . Oversulfated CS, DS, and hybrid CS/DS structures have been found strongly implicated in brain development [9] . Several reports point out that CS/DS chains of mammalian brains are character-. ized by an elevated degree of micro heterogeneity and highly suI fated domains containing a cluster of oversulfated disaccharides [10] . Lately, a novel neurobiological function was attributed to oversulfated DS. In an experimental model on cultures of hippocampal neurons from E16 mouse brains [11] , physiological neuritogenesis during brain development was unequivocally associated to oversulfated DS structures. A prerequisite for collecting reliable information on brain proteoglycan glycosylation is the development of advanced analytical methods capable to offer data upon epimerization, suI fate content, and its distribution. The arsenal of currently available sophisticated mass spectrometric (MS) techniques opened new perspectives in this regard. Thoroughly optimized methods based on electrospray (ESI) MS were shown to provide accurate results on unsulfated and regularly and oversulfated domains in chondroitin and dermatan oligomers [12, 13] . For CS/DS C. Flangea et a!.
and also HS and KS, the incidence of regular and/or irregular sulfation pattern(s) was directly documented by sequencing single· components. in tandem MS (MS/MS) experiments by collision-induced [14] [15] [16] [17] [18] [19] (CID) or electron detachment [20, 21] dissociation.
Due to its potential to reduce the in-source loss of labile attachments such as suI fate ester groups' and increase analysis speed, sensitivity, and ionization effjCiency, chipbased nanoelectrospray ionization (nanoESI) einerged reently as a valuable to'ol in'glycosaminoglycOl:nics [22] [23] [24] [25] [26] .
Although MS demonstrated its ability to offer disti.nctive insights into the domain structure of GAGs,so far no structural analysis of CNS-derived GAGs was pursued by employing mass spectrometry-based methodologies. .
To close this gap, here, mass spectrometry is.for the first time introduced in glycomics of brain glycosaminoglycans and particularly applied to brain-associated CS/DS oligosaccharides. The newly developed MS method is· based on fully automated chip nanoESI perfonned' oh a NanoMate 400 robot in direct coupling with a high capacity ion trap (HCT) mass spectrometer. CS and DS, obtained' by (3-elimination and selective digestion of hybrid chains from wild-type mouse brain, were screened and, sequenced by NanoMate HCTMS operating in negative ion· ·mode. By this advanced MS protocol, we were able to identify brain DS repeats of regular sulfationpattern as well as an unusual bisulfated CS disaccharide. Moreover, sequencing in the multistage mass spectrometry (MS dissolved in 4 M guanidinum chloride buffer and rotated over night at 4 QC. For purification, the sample was centrifuged, and the supematant was diluted with starting buffer (20 mM Tris/HCl pH 7.4) containing 150 mM NaCl. This solution was applied on DEAE-tris-Acryl M prepared in a Pasteur pipette with a bedvolume of 0.5 mL and washed with 5x bedvolume starting buffer containing 150 mM NaCl followed by 300 mM NaCl [27] . The CS/DS proteoglycans were eluted with 3x bedvolume starting buffer containing 1 M NaCl, desalted and concentrated. One-half volume was digested with 50 mU/assay chondroitin AC I lyase in 200 ilL 50 mM Tris/HCl, pH 8.0, containing 60 mM sodium acetate, 60 mM NaCI, 0.01% bovine serum albumin, and 3 mM NaN 3 for 2 h at 37 QC (Seikagaku Kogyo, Tokyo, Japan) as described previously [27, 28] . In parallel, the other one-half volume was digested with 50 mU/ assay chondroitin B lyase. Size fractionation of oligosaccharides was performed on a Superdex Peptide HRI0/30 disaccharides obtained from recombinant expressed decorin digested with chondroitin ABC lyase [27] . The disaccharide fractions were pooled and desaIted on a prepacked D-Salt column (MWCO 5000) (Pierce, Rockford, IL) [29] .
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Mass spectrometry
Mass spectrometer All experiments were conducted on a High Capacity Ion Trap Ultra (HCT Ultra, PTM discovery) mass spectrometer from Bruker Daltonics, Bremen, Gennany. All mass spectra were acquired in the mass range 100--1,000 mlz, with a scan speed of 8,000mlzs-l • Tandem mass spectrometry was carried out by collision-induced dissociation using He as the collision gas. For MS2_MS3 sequencing, the precursor ions were selected within an isolation width of 2 u. Each fragmentation spectrum was obtained by accumulating scans at variable RF signal amplitudes within 0.40--0.80 V, ramped from 30% to 200% within 40 ms per single spectrum and a fragmentation cutoff default of 27% of the precursor ion mlz.
The mlz scale of the mass spectrum was calibrated by use of an extemal calibration standard G2421A electrospray "timing mix" from Agilent Technologies (Santa Rosa, CA, USA). The reference provided in negative ion mode a spectrum with a fair ionic coverage of the mlz range scanned in both MS and CID MS" experiments. The obtained mass accuracy was situated within 10--40 ppm, which is a nonnal range of an HCT MS instrument.
'ntens. The assignment of molecular ions to a certain composition was made by exact mass calculation; taking as a base the previously acquired infonnation [22, 24, 30, 31] and CS/DS biosynthesis pathway criteria. Fragment ion designation followed generally the published recommendations [32, 33] .
Fully automated chip-based nanoelectrospray Samples were infused into the mass spectrometer using a fully automated chip-based nanoelectrospray system, NanoMate robot incorporating ESI 400 Chip technology (Advion BioSciences, Ithaca, USA). NanoMate is controlled and manipulated by ChipSoft 8.1.0 software operating under Windows system. The robot was coupled to the HCT Ultra mass spectrometer via an in-laboratory made mounting system, which allows robot O-xyz positioning with respect to HCT counterelectrode as described by us before [31, 34] .
Five-microliter aliquots of the working sample solutions were loaded into the NanoMate 96-weIl plate. The robot was programmed to aspirate the whole volume of sample and afterwards deliver the sample to the inlet side of the 400 microchip. NanoMate HCT MS system was tuned for operating in the negative ion mode previously demonstrated [17, 35, 36] as the most appropriate ionization mode for glycosaminoglycans. Electrospmy was initiated by applying a voltage of -lA kVon the pipette tip, 0.30 psi nitrogen back pressure, and 50 psi pressure of nitrogen nebulizer on MS. In order to prevent possible in-source fmgmentation, the potential difference between the end of the transfer capillary and the skimmer (Cap Exit) was set to 50 V. The source block maintained at the constant temperature of 200 QC provided an optimal desolvation of the genemted droplets without the need of desolvation gas. Following sample infusion and MS analysis, the pipette tip was ejected, and a new tip and nozzle were used for each sample, thus preventing any crosscontamination or carryover. Each chip nozzle had an intemal diameter of 2.5 f.tm, which under the given conditions delivered a working flow mte of approximately 50 nLlmin.
Results and discussions

Compositional analysis of bmin DS and CS disaccharide fractions
Dennatan sulfate disaccharide fraction, obtained after depolymerization with chondroitin B lyase dissolved in methanol, was loaded onto the microtiter plate of the 
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NanoMate robot and submitted to negative nanoESI chip for infusion and HCT MS analysis. Resulting DS mass spectrum as a sum of 60 scans acquired over 2 min is presented in Fig. 1 . According to the mass calculation, the most abundant ion observed at m/z 458.24 was assigned a composition of monosulfated 4,5-L1-[IdoA-GaINAc]. Such an assignment is based on the known specificity of chondroitin Iyases. Chondroitin B lyase cleaves the glycosidic linkage between GalNAc and L-IdoA, while chondroitin AC I lyase cleaves the linkage between GalNAc and D-GIcA [28] , with the .fonnation of a 4,5 double bond at HexA and a water molecule elimination in both cases. These enzymes belong to the class of Iyases that cleave glycosidic bond by (3-elimination reaction, following this strict specificity, which does not depend on the sulfation content and/or pattern. Although after the action of the enzyme the stereochemistry is lost, in order to facilitate the discrimination between the uronic acids, we kept denoting them with their original IdoA and GIcA nomenclature. The mass spectrum in Fig. 1 MS analysis of disaccharide fraction obtained after depolymerization with AC I lyase rendered the spectrum presented in. Fig. 2 . In this spectrum, the most abundant ion at mlz 458.30 corresponds to a regularly mono sui fated 4,5-~-[GlcA-GaINAc] species, while the ions at mlz 476.27 and mlz 498.29. disclose the presence of one irregular monosulfated [GlcA-GaINAc] compound lacking the C4-C5 double bond (Fig. 2) . Most probably, this species represents the nonreducing end of the original hybrid CS/DS GAG chain. Additionally, the occurrence of a rare motif having the composition of bisulfated 4,5- Obtained mass spectrum acquired over 60 s is presented in Fig. 3 . As visible, employed optimized sequencing conditions enhanced the formation of sulfated fragment ions diagnostic for sulfate localization within the disaccharide. The ions at mlz 282.14 and 300.15 assigned according to Domon and Costello nomenclature [32] to ZI-and Ylresult after GleA-GaINAc glycosidic bond cleavage; they correspond to monosulfated GalNAc and therefore are diagnostic for the localization of the sui fate group at this monosaccharide residue. GalNAc monosulfation is proved also by the ring cleavage ion at mlz 324.15 assigned to S03 -groups is presented. This mass spectrum acquired also for 60 s exhibits a number of fragment ions corresponding to an unusual disaccharide structure. Z)-and Y)-ions at mlz 282.22 and 300.15 as well as O,2X l -at mlz 342.10 indicate that one sulfate group is localized at GaINAc, while B l -and C l -ions at mlz 237.19 and 255.24 are diagnostic for 4,5-llGlcA monosulfation. Consequently, the precursor ion corresponds to a bisulfated 4,5-ll-[GlcA-GaINAc] structure in which each monosaccharide residue bears one sui fate ester group. Certainly, for this atypical species, unambiguous identification of sulfation sites at both mono mer rings is of high biological significance. To identify the exact position of these sulfates within 4,5-ll-GlcA and GalNAc moieties of the investigated oversulfated disaccharides species, the ions at mlz 255.24 corresponding to 4,5-llOIcA and mlz 282.22 corresponding to monosulfated GalNAc were submitted to fragmentation analysis in CID MS 3 experiments. 5 ). CID MS 3 of the ion at mlz 282.22 corresponding according to mass calculation· to monosulfated GalNAc detected as a ZI-fragment ion in MS2 is depicted in Fig. 6 . Inspection of the spectrum reveals that optimized fragmentation conditions in terms of RP signal amplitudes enhanced the formation of ring cleavage ions highly useful for sulfation site assessment. In this regard, the most relevant are 2.4X-ion at mlz 240.00 and its dehydrated fonn e,4Ar-H 2 0 ion at mlz 222.20, which support a structure having the sulfation site located in position 6 of the GalNAc ring. This concept is additionally confirmed by the higher relative abundance of Zl-ion in comparison to that of Y [-ion. According to previous investigations [37, 38] , such a distribution of signal relative intensities is consistent with GalNAc (6S) structure. e,4AzlBd-and o,4A z -ion fragment variants corroborate for the occurrence of sulfation in position 4. To bring unequivocal evidence upon sui fate position at GaINAc, the ion at m/z 300.09, identified as an Y,-in MS2 experiment, WflS isolated and submitted to CID MS3. Obtained mass spectrum is presented in Fig. 8 . Obviously, optimized fragmentation conditions favored the formation of three-ring cleavage ions assigned to o,2A-, 0,zA--H 2 0, and 2,4A-. The latter one marked by a star is unambiguously diagnostic for sulfation in position 4 of GaINAc, a conclusion supported also by the higher intensity of the signal corresponding to Y 1-ion in comparison with that of ZI-ion.
Conclusions
The aim of this study was to assess for the first time the feasibility of mass spectrometry in glycomics of brain glycosaminoglycans. For this purpose, an advanced, highly sensitive and rapid MS method based on fully automated chip (-) nanoESI HCT CID MS" was optimized and applied to CS and DS oligosaccharides extracted and purified from wild-type mouse brain. Chip-based nanoESI MS screening in the negative ion mode allowed for the identification of CS and DS disaccharide species of regular sulfation patterns as well as an unusual bisulfated CS motif. Detailed structural characterization and determination of sulfation sites were achieved by CID MS2-MS3 fragmentation. While CID MS/MS of regular and undersulfated GAGs was successfully performed before [29, 33, 35] , MS/MS analysis of over sui fated domains [12] [13] [14] 19] did not allow an unequivocal determination of oversulfation sites. In a previous study conducted by CID MS/MS [12] , although the sulfation of L-IdoA could be demonstrated, clear-cut discrimination between the structural motifs with either bisulfated D-GaINAc or monosulfated D-GlcA could not be achieved [26] . To overcome this limitation of single-stage CID fragmentation of oversulfated GAGs, we have recently developed [24] a methodology based on enzyme cleavage and multistage CID experiments. Application of CID MSn_ based protocol to oversulfated CS/DS hexamers from 2497 human decorin led to the first unequivocal determination of excess sulfation sites along the GAG chain. In the present study, this novel protocol for oversulfated GAG analysis was for the first time optimized for CS/DS species expressed in CNS. By this method, noveI4,5-f:.-[GleA(3S)-GaINAc(6S)] and 4,5-f:.-[IdoA-GaINAc(4S)] motifs were discovered and characterized. The presence of 4,5-f:.-[GlcA (3S)-GaINAc(6S)] confirmed here for the first time by chipbased nanoESI CID MS n appears to corroborate the existence of the unusual GleA 3-0-sulfotransferase reported in a few studies [39] [40] [41] . Nevertheless, the distribution of GlcA (3S) and sequences adjacent to GleA (3S) in CS polymer chains remains, to date less understood. Since several reports postulated that 3-0-sulfation might be involved or even trigger CS chain termination [39, 42] , we suspect that the identified 4,5-f:.-[GleA(3S)-GaINAc (6S)] could be located close to the GAG chain extremity. Although such terminal motifs have not yet been confirmed, our findings appear to support the assumptions regarding their occurrence in CNS [43] . The methodology presented here is adaptable to all categories of glycosaminoglycans expressed in central nervous system and is likely to become further improved in terms of application to longer CNS GAG chains and extension towards GAG species associated to human brain in health and disease. Method straightforward application to research oriented towards elucidation of CS/DS sulfation role in brain development, maturation, and aging as well as various CNS pathologies is envisaged. Moreover, further studies focused on quantifying sulfation patterns in development or disease using combined liquid chromatographychip-based nanoESI CID MS n are deemed necessary and therefore planned.
